InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Girard Armand, 副总经理. Director active across 1 company, notably Glycomimetics INC. Aggregated, 2 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €9k. History available since 9 March 2022. The latest transaction was filed on 11 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Armand Girard is the Executive Vice President and Chief Business Officer at GlycoMimetics Inc. He oversees the commercial operations and growth strategy of the company. GlycoMimetics Inc. is a biopharmaceutical company focusing on developing treatments for serious diseases.